(Q33843608)

English

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun (English)

1 reference

Europe PubMed Central

29 July 2017

radiation therapy

0 references

6

object named as

Ritsuko Komaki

1 reference

Europe PubMed Central

29 July 2017

5

object named as

Radhe Mohan

1 reference

Europe PubMed Central

29 July 2017

author name string

Xiaodong Zhang

1

1 reference

Europe PubMed Central

29 July 2017

Yupeng Li

2

1 reference

Europe PubMed Central

29 July 2017

Xiaoning Pan

3

1 reference

Europe PubMed Central

29 July 2017

Li Xiaoqiang

4

1 reference

Europe PubMed Central

29 July 2017

James D Cox

7

1 reference

Europe PubMed Central

29 July 2017

Joe Y Chang

8

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

5 August 2009

1 reference

Europe PubMed Central

29 July 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

29 July 2017

77

1 reference

Europe PubMed Central

29 July 2017

2

1 reference

Europe PubMed Central

29 July 2017

357-366

1 reference

Europe PubMed Central

29 July 2017

Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

5 July 2018

Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

5 July 2018

Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

5 July 2018

Determination of patient-specific internal gross tumor volumes for lung cancer using four-dimensional computed tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

4D Proton treatment planning strategy for mobile lung tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Four-dimensional proton treatment planning for lung tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Hypofractionated proton beam radiotherapy for stage I lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Methodologies and tools for proton beam design for lung tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868090

29 October 2018

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19660879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19660879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19660879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2009.04.028

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33843608&oldid=1533437049"